Gilead Sciences Inc (GILD)
90.20
+0.36
(+0.40%)
USD |
NASDAQ |
Nov 05, 16:00
89.76
-0.44
(-0.49%)
After-Hours: 18:51
Gilead Sciences Price: 90.20 for Nov. 5, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 89.49 | 90.71 | 89.37 | 89.84 | 6.036M |
| Nov 01, 2024 | 88.31 | 89.57 | 88.19 | 89.51 | 6.486M |
| Oct 31, 2024 | 87.94 | 89.28 | 87.74 | 88.82 | 5.895M |
| Oct 30, 2024 | 87.90 | 88.37 | 87.48 | 88.29 | 5.847M |
| Oct 29, 2024 | 88.38 | 88.52 | 86.81 | 88.08 | 6.656M |
| Oct 28, 2024 | 89.24 | 89.42 | 88.52 | 88.76 | 5.962M |
| Oct 25, 2024 | 89.45 | 89.74 | 88.45 | 89.00 | 5.735M |
| Oct 24, 2024 | 87.72 | 89.22 | 87.62 | 88.78 | 7.184M |
| Oct 23, 2024 | 88.15 | 88.39 | 87.14 | 87.23 | 4.373M |
| Oct 22, 2024 | 85.68 | 88.36 | 85.60 | 88.16 | 6.044M |
| Oct 21, 2024 | 86.64 | 87.27 | 85.92 | 86.29 | 4.451M |
| Oct 18, 2024 | 86.79 | 87.17 | 86.01 | 86.72 | 4.365M |
| Oct 17, 2024 | 86.92 | 87.65 | 86.59 | 87.36 | 4.286M |
| Oct 16, 2024 | 85.83 | 86.82 | 85.82 | 86.75 | 3.181M |
| Oct 15, 2024 | 85.18 | 86.64 | 84.80 | 85.82 | 5.133M |
| Oct 14, 2024 | 84.92 | 85.34 | 84.34 | 85.05 | 3.493M |
| Oct 11, 2024 | 84.86 | 84.98 | 84.16 | 84.95 | 3.982M |
| Oct 10, 2024 | 85.83 | 85.94 | 84.59 | 84.67 | 3.815M |
| Oct 09, 2024 | 85.18 | 86.84 | 85.06 | 86.14 | 6.162M |
| Oct 08, 2024 | 84.52 | 85.39 | 84.32 | 85.21 | 4.593M |
| Oct 07, 2024 | 85.05 | 85.66 | 84.34 | 84.43 | 4.693M |
| Oct 04, 2024 | 84.34 | 84.96 | 83.98 | 84.59 | 4.054M |
| Oct 03, 2024 | 84.25 | 84.93 | 84.01 | 84.17 | 4.086M |
| Oct 02, 2024 | 83.33 | 85.42 | 83.10 | 84.74 | 6.042M |
| Oct 01, 2024 | 83.82 | 83.98 | 82.82 | 83.94 | 6.619M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
56.65
Minimum
Dec 30 2020
90.20
Maximum
Nov 05 2024
71.26
Average
69.66
Median
Mar 25 2020
Price Benchmarks
| Merck & Co Inc | 101.65 |
| Eli Lilly and Co | 806.37 |
| Amgen Inc | 319.23 |
| Pfizer Inc | 27.98 |
| Bristol-Myers Squibb Co | 55.94 |
Price Related Metrics
| PE Ratio | 110.00 |
| PS Ratio | 4.063 |
| Price to Book Value | 6.143 |
| Price to Free Cash Flow | 16.38 |
| Earnings Yield | 0.91% |
| Market Cap | 112.30B |
| Operating PE Ratio | 15.67 |
| Normalized PE Ratio | 21.16 |